webinar: combination of durvalumab, bevacizumab, tremelimumab & transarterial chemoembolization
Published 3 years ago • 437 plays • Length 44:01Download video MP4
Download video MP3
Similar videos
-
51:48
webinar: novel treatment approaches for intrahepatic cholangiocarcinoma
-
1:15
montblanc: sequential or up-front durvalumab, tremelimumab, bevacizumab in unresectable hcc
-
58:24
webinar: hepatic arterial infusion (hai) pump trial for icc at ohsu
-
59:37
icrn/ens-cca translational science webinar series: "role of cytotoxic chemo in cholangiocarcinoma”
-
51:37
webinar: a global study of the genetics of cholangiocarcinoma
-
1:03:30
webinar: can local therapies help patients with intrahepatic cholangiocarcinoma?
-
56:27
ccf webinar: a clinical trial for a potential new ther2apy for biliary tract cancers
-
35:14
webinar: the release trial and the technology behind
-
26:50
ac22 - topaz-1 trial in biliary tract cancer
-
1:04:18
ccf webinar: cholangiocarcinoma 101
-
1:30
dr. overman on the combination of atezolizumab and bevacizumab in hcc
-
1:02:46
ccf webinar: clinical trials for those with local/regional & advanced cholangiocarcinoma
-
1:14:36
webinar: targeted treatment strategies for advanced cholangiocarcinoma -results of promising trials
-
1:14
phase i study of abbv-383, a bcma×cd3 bispecific antibody, in r/r myeloma
-
19:13
ac21 - tim pawlik: surgical management of intrahepatic cholangiocarcinoma
-
58:54
webinar: nutide 121 clinical trial
-
34:49
ccf grantee webinar series i
-
4:16
cholangiography: new techniques are best